TBPH
Theravance Biopharma Inc
Price:  
9.29 
USD
Volume:  
278,154.00
Cayman Islands | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

TBPH Relative Valuation

-176.5%
Upside

As of 2024-05-18, the Relative Valuation of Theravance Biopharma Inc (TBPH) is (7.11) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.29 USD, the upside of Theravance Biopharma Inc based on Relative Valuation is -176.5%.

The range of the Relative Valuation is (6.82) - (7.59) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 6.0x - 6.7x 6.5x
Forward P/E multiples 6.0x - 7.0x 6.0x
Fair Price (6.82) - (7.59) (7.11)
Upside -173.4% - -181.8% -176.5%
9.29 USD
Stock Price
(7.11) USD
Fair Price

TBPH Relative Valuation - Historical P/E Data

Date P/E
2024-05-17 -8.17
2024-05-16 -8.44
2024-05-15 -8.66
2024-05-14 -8.26
2024-05-13 -8.43
2024-05-10 -8.25
2024-05-09 -8.33
2024-05-08 -8.35
2024-05-07 -8.39
2024-05-06 -8.44
2024-05-03 -8.32
2024-05-02 -8.24
2024-05-01 -7.78
2024-04-30 -7.42
2024-04-29 -7.91
2024-04-26 -8.02
2024-04-25 -8.04
2024-04-24 -8.07
2024-04-23 -8.11
2024-04-22 -8.32
2024-04-19 -8.22
2024-04-18 -8.09
2024-04-17 -8.37
2024-04-16 -8.52
2024-04-15 -8.73
2024-04-12 -8.45
2024-04-11 -7.85
2024-04-10 -8.39
2024-04-09 -8.34
2024-04-08 -8.33
2024-04-05 -8.19
2024-04-04 -8.04
2024-04-03 -8.17
2024-04-02 -8.00
2024-04-01 -7.94
2024-03-28 -7.89
2024-03-27 -7.92
2024-03-26 -7.76
2024-03-25 -7.70
2024-03-22 -7.85
2024-03-21 -7.88
2024-03-20 -7.92
2024-03-19 -7.78
2024-03-18 -7.61
2024-03-15 -7.60
2024-03-14 -7.57
2024-03-13 -7.74
2024-03-12 -7.49
2024-03-11 -7.54
2024-03-08 -7.58